US 12048691
High dosage tebipenem pivoxil tablet formulation
granted A61KA61K31/427A61K9/2009
Quick answer
US patent 12048691 (High dosage tebipenem pivoxil tablet formulation) held by SPERO THERAPEUTICS, INC. expires Mon Jul 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- SPERO THERAPEUTICS, INC.
- Grant date
- Tue Jul 30 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 25
- CPC classes
- A61K, A61K31/427, A61K9/2009, A61K9/2027, A61K9/2054